Erratum to "Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway".

Lu Huang, Qiong Yang, Huihong Chen, Zhenggeng Wang, Qi Liu, Shuhua Ai

Open access · goldAbstract readPublished Erratum

In one paragraph

Article in Open medicine (Warsaw, Poland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact, top 93% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

Erratum for
Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway.2022

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Lu HuangDepartment of Gastroenterology, The Second Affiliated Hospital, Hengyang Medical School, University of South China, No. 35 Jiefang Road, Hengyang City, 421001, Hunan Province, Hunan, China.

Qiong YangDepartment of Gastroenterology, The Second Affiliated Hospital, Hengyang Medical School, University of South China, No. 35 Jiefang Road, Hengyang City, 421001, Hunan Province, Hunan, China.

Huihong ChenDepartment of Gastroenterology, The Second Affiliated Hospital, Hengyang Medical School, University of South China, No. 35 Jiefang Road, Hengyang City, 421001, Hunan Province, Hunan, China.

Zhenggeng WangDepartment of Gastroenterology, The Second Affiliated Hospital, Hengyang Medical School, University of South China, No. 35 Jiefang Road, Hengyang City, 421001, Hunan Province, Hunan, China.

Qi LiuDepartment of Gastroenterology, The Second Affiliated Hospital, Hengyang Medical School, University of South China, No. 35 Jiefang Road, Hengyang City, 421001, Hunan Province, Hunan, China.

Shuhua AiDepartment of Gastroenterology, The Second Affiliated Hospital, Hengyang Medical School, University of South China, No. 35 Jiefang Road, Hengyang City, 421001, Hunan Province, Hunan, China.

University of South China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.1515/med-2022-0453.].

Identifiers

PMID35799604

DOI10.1515/med-2022-0501

PMCPMC9191560

OpenAlexW4285164705

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.